Healthcare Stocks in Focus as Earnings Approach

Pfizer, Inc. (NYSE:PFE) will unveil its latest earnings on Tuesday, May 1, 2012. The average analyst estimate is for profit of 56 cents per share, a decline of 6.7% from the company’s actual earnings for the year-ago quarter. During the past three months, the average estimate has moved down from 57 cents. Between one and three months ago, the average estimate moved down. It has been unchanged at 56 cents during the last month. For the year, analysts are projecting net income of $2.25 per share, a decline of 2.6% from last year.

Last quarter, the company beat estimates by 3 cents, coming in at profit of 50 cents a share versus the estimate of net income of 47 cents a share. It marked the fourth straight quarter of beating estimates. On average, analysts predict $15.46 billion in revenue this quarter, a decline of 6.3% from the year-ago quarter. Analysts are forecasting total revenue of $62.15 billion for the year, a decline of 7.8% from last year’s revenue of $67.42 billion.

Becton, Dickinson and Co. (NYSE:BDX) will unveil its latest earnings on Tuesday, May 1, 2012. The average estimate of analysts is for net income of $1.38 per share, no change from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from $1.42. Between one and three months ago, the average estimate moved down. It has been unchanged at $1.38 during the last month. Analysts are projecting profit to rise by 0.9% compared to last year’s $5.67.

Last quarter, the company saw profit of $1.17 per share versus a mean estimate of net income of $1.17 per share. This comes after two consecutive quarters of exceeding expectations. On average, analysts predict $1.94 billion in revenue this quarter, a rise of 1% from the year-ago quarter. Analysts are forecasting total revenue of $7.88 billion for the year, a rise of 0.6% from last year’s revenue of $7.83 billion.

Biogen Idec, Inc. (NASDAQ:BIIB) will unveil its latest earnings on Tuesday, May 1, 2012. The average analyst estimate is for profit of $1.44 per share, a rise of 1.4% from the company’s actual earnings for the year-ago quarter. During the past three months, the average estimate has moved down from $1.47. Between one and three months ago, the average estimate was unchanged. It has since dropped over the last month. Analysts are projecting profit to rise by 4.8% compared to last year’s $6.12.

Last quarter, the company beat estimates by 4 cents, coming in at net income of $1.50 per share against an estimate of profit of. The company also topped expectations in the third quarter of the last fiscal year. Analysts predict a rise of 9.2% in revenue from the year-earlier quarter to $1.31 billion.

DaVita, Inc. (NYSE:DVA) will unveil its latest earnings on Tuesday, May 1, 2012. The average analyst estimate is for profit of $1.45 per share, a rise of 51% from the company’s actual earnings for the year-ago quarter. During the past three months, the average estimate has moved down from $1.46. Between one and three months ago, the average estimate moved down. It has been unchanged at $1.45 during the last month. For the year, analysts are projecting net income of $6.23 per share, a rise of 21.2% from last year.

The company topped estimates last quarter after missing forecasts the quarter prior. In the fourth quarter of the last fiscal year, it reported profit of $1.58 per share against a mean estimate of net income of $1.48 per share. In the third quarter of the last fiscal year, it missed forecasts by one cent. Analysts are projecting a rise of 14.9% in revenue from the year-earlier quarter to $1.85 billion.

Hospira, Inc. (NYSE:HSP) will unveil its latest earnings on Tuesday, May 1, 2012. The average estimate of analysts is for profit of 46 cents per share, a decline of 50.5% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from 50 cents. Between one and three months ago, the average estimate moved down. It has been unchanged at 46 cents during the last month. For the year, analysts are projecting net income of $2.17 per share, a decline of 28.6% from last year.

Last quarter, the company topped estimates by 0 cents, coming in at profit of 51 cents per share against a mean estimate of net income of 45 cents. The company fell in line with estimates in the third quarter of the last fiscal year. On average, analysts predict $951 million in revenue this quarter, a decline of 4.9% from the year-ago quarter. Analysts are forecasting total revenue of $4.01 billion for the year, a decline of 1.2% from last year’s revenue of $4.06 billion.